Uma grande lacuna em nossa capacidade de teste geral permanece não preenchida - a capacidade de dizer às pessoas de maneira rápida e confiável, se elas foram infectadas.
Educação
- MBA, Kellogg School of Management, Northwestern University
- BS, Engenharia Química, Stanford University
Sean Mathewson is a core member of Boston Consulting Group’s Health Care and Strategy practices with experience in strategy, corporate development, and digital and analytics topics. He has also led projects with BCG clients in public sector and social impact areas. Among other topics, Sean has expertise in portfolio strategy, research and development, inorganic growth and M&A, commercial launch in biopharma, and Total Shareholder Return.
Sean’s current focus is on growth and portfolio strategy at leading biopharmaceutical, life science, and medical technology companies. He also works with clients to define and implement digital and analytics approaches in sales and marketing.
Antes de ingressar no BCG, Sean trabalhou em pesquisa e desenvolvimento na Genentech. Enquanto estava em Stanford, Sean co-autoria uma publicação sobre química de proteínas de células-tronco embrionárias, e ele é o co-inventor de uma patente para software de análise de bioquímica. 医療機器・メディカルテクノロジー
